InvestorsObserver
×
News Home

Will Satsuma Pharmaceuticals Inc (STSA) Stay at the Top of the Healthcare Sector?

Monday, May 08, 2023 03:43 PM | InvestorsObserver Analysts

Mentioned in this article

Will Satsuma Pharmaceuticals Inc (STSA) Stay at the Top of the Healthcare Sector?

A rating of 72 puts Satsuma Pharmaceuticals Inc (STSA) near the top of the Healthcare sector according to InvestorsObserver. Satsuma Pharmaceuticals Inc's score of 72 means that it ranks higher than 72% of stocks in the sector. In addition, its overall score of 35 ranks it higher than 35% of all stocks.

Overall Score - 35
STSA has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on STSA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Satsuma Pharmaceuticals Inc Stock Today?

Satsuma Pharmaceuticals Inc (STSA) stock is unchanged 0.47% while the S&P 500 has gained 0.04% as of 3:40 PM on Monday, May 8. STSA is flat $0.00 from the previous closing price of $1.07 on volume of 153,039 shares. Over the past year the S&P 500 is higher by 3.68% while STSA is down -64.24%. STSA lost -$2.19 per share the over the last 12 months. Click Here to get the full Stock Report for Satsuma Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App